Skip to content

IKS03 in Advanced B cell NHL

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-512415-45-00
Acronym
IKS03-01
Enrollment
80
Registered
2024-09-13
Start date
2025-01-14
Completion date
Unknown
Last updated
2026-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced B cell Non-Hodgkin Lymphomas

Interventions

None listed

Sponsors

Iksuda Therapeutics Limited
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Italy, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026